- Home
- IIM vs CRMD Comparison
IIM vs CRMD Comparison
Compare IIM & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$7.97
Company Overview
Basic Information| Metric | IIM | CRMD |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.8M | 618.2M |
| IPO Year | 1994 | 2009 |
Fundamental Metrics
Financial Performance| Metric | IIM | CRMD |
|---|---|---|
| Price | $12.05 | $7.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 123.5K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.55 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $11.20 | $6.13 |
| 52 Week High | $13.17 | $17.43 |
Technical Indicators
Market Signals| Indicator | IIM | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 56.06 |
| Support Level | $11.90 | $6.28 |
| Resistance Level | $12.69 | $8.53 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 21.18 | 33.11 |
Price Performance
Historical Comparison IIM
CRMD
About IIM Invesco Value Municipal Income Trust
Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income that is exempt from federal income tax.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.